The role of the c-Rel subunit has been reported in human diseases, such as cardiac hypertrophy, fibrosis, and inflammatory bowel disease; its dysregulation has been observed in both liquid and solid tumors with an oncogenic or tumor suppressor function [27,49]. Here, REL is linked to cardiac hypertrophy.